CAMBRIDGE, Mass. (AP) — CAMBRIDGE, Mass. (AP) — Editas Medicine Inc. (EDIT) on Wednesday reported a loss of $40.3 million in its second quarter.
On a per-share basis, the Cambridge, Massachusetts-based company said it had a loss of 56 cents.
The results beat Wall Street expectations. The average estimate of 10 analysts surveyed by Zacks Investment Research was for a loss of 76 cents per share.
The genome editing company posted revenue of $2.9 million in the period, which did not meet Street forecasts. Five analysts surveyed by Zacks expected $6.3 million.
Copyright © 2023 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.